Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Geez!...The silence here is deafening!

<< Previous

Bullboard Posts

Next >>

Comment by TMAZZ21on Dec 13, 2020 8:55pm

377 Views

Post# 32097047

RE:RE:Geez!...The silence here is deafening!

Prone to massive swings really!

Look at the charts from March to October it was training in the $2.00 range sometimes below and sometimes above.

Like I said many times - The CEO Mr. Matt Coffey should step aside and bring in someone who has a following in the States. Otherwise this stock will continue to be manuiplated and the ones holding the bag will be the share holders.

<< Previous

Bullboard Posts

Next >>

The top TSX healthcare stocks under $1